REGENXBIO Inc.

Historical 13F Holders

Symbol
RGNX
CUSIP
75901B107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 75901B107 since 12/18/2024, largest first.

Filer % of Class Filed
Redmile Group, LLC 13G/A
9.9% 8/14/2025
Event 6/30/2025
BlackRock, Inc. 13G/A 7.3% 4/24/2025
Event 3/31/2025
State Street Corp 13G 5.3% 5/12/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
JPMorgan Chase & Co 13G/A 4.4% 6/4/2026
Event 5/29/2026
BlackRock Portfolio Management LLC 13G/A 4.1% 1/21/2026
Event 12/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 6.25 k $47.1 k
2026 Q2 180 42.4 M $508 M
2026 Q1 192 42.7 M $356 M
2025 Q4 188 41.2 M $594 M
2025 Q3 179 45.4 M $439 M
2025 Q2 171 42.1 M $345 M
2025 Q1 173 41.7 M $298 M
2024 Q4 186 42.1 M $325 M
2024 Q3 197 46.2 M $484 M
2024 Q2 190 47.9 M $561 M
2024 Q1 201 49.0 M $1.03 B
2023 Q4 184 44.2 M $794 M
2023 Q3 171 37.2 M $612 M
2023 Q2 180 37.1 M $742 M
2023 Q1 184 37.1 M $707 M
2022 Q4 193 38.4 M $871 M
2022 Q3 192 35.1 M $929 M
2022 Q2 176 36.2 M $896 M
2022 Q1 200 35.1 M $1.16 B
2021 Q4 186 35.6 M $1.17 B
2021 Q3 196 33.4 M $1.40 B
2021 Q2 185 33.6 M $1.30 B
2021 Q1 198 32.9 M $1.12 B
2020 Q4 206 28.1 M $1.27 B
2020 Q3 177 28.5 M $785 M
2020 Q2 191 29.4 M $1.08 B
2020 Q1 181 29.0 M $939 M
2019 Q4 200 30.5 M $1.25 B
2019 Q3 178 29.2 M $1.04 B
2019 Q2 207 29.9 M $1.53 B
2019 Q1 225 30.2 M $1.73 B
2018 Q4 195 30.3 M $1.27 B
2018 Q3 222 29.8 M $2.25 B
2018 Q2 191 26.2 M $1.88 B
2018 Q1 129 22.7 M $678 M
2017 Q4 116 22.1 M $734 M
2017 Q3 96 22.3 M $734 M
2017 Q2 89 22.7 M $448 M
2017 Q1 87 20.8 M $402 M
2016 Q4 80 20.9 M $387 M
2016 Q3 71 16.9 M $237 M
2016 Q2 69 18.2 M $147 M
2016 Q1 65 16.7 M $180 M
2015 Q4 68 15.1 M $248 M
2015 Q3 49 15.1 M $327 M